BIOFRONTERA AG (BFRA) Stock Balance Sheet
NASDAQ:BFRA - Nasdaq - ADR
| MRQ (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.54M | 16.55M | 11.12M | 19.45M | 11.08M | |||
| Marketable Securities | 1.37M | 532.00K | 1.08M | 794.00K | 571.00K | |||
| Receivables | 2.81M | 3.51M | 5.04M | 3.45M | 1.61M | |||
| Inventories | 4.26M | 4.67M | 4.07M | 3.18M | 3.73M | |||
| Other Current Assets | 2.02M | 868.00K | 1.20M | 715.00K | 1.45M | |||
| Total Current Assets | 40.00M | 26.13M | 22.49M | 27.59M | 18.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.22M | 5.05M | 5.23M | 794.00K | 746.00K | |||
| Intangibles | 17.48M | 17.69M | 22.85M | 352.00K | 648.00K | |||
| Other Non-Current Assets | 7.52M | 7.53M | 7.79M | 10.40M | N/A | |||
| Total Non-Current Assets | 29.22M | 30.27M | 35.87M | 11.55M | 1.39M | |||
| TOTAL ASSETS | 69.23M | 56.39M | 58.36M | 39.13M | 19.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.02M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 20.60M | 1.14M | 1.21M | 165.00K | 170.00K | |||
| Accounts Payable | 3.32M | 1.62M | 4.20M | 1.81M | 1.62M | |||
| Other Current Liabilities | 5.81M | 5.52M | 6.17M | 5.80M | 2.32M | |||
| Total Current Liabilities | 31.75M | 8.29M | 11.58M | 7.77M | 4.11M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.00M | 22.74M | 22.11M | 13.46M | 12.36M | |||
| Other Non-Current Liabilities | 19.58M | 17.99M | 14.72M | 1.54M | 0.00 | |||
| Total Non-Current Liabilities | 21.58M | 40.73M | 36.83M | 15.01M | 12.35M | |||
| TOTAL LIABILITIES | 53.33M | 49.02M | 48.41M | 22.78M | 16.47M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -180.40M | -165.73M | -152.71M | -145.38M | -35.74M | |||
| Additional Paid In Capital | 137.36M | 123.49M | 118.10M | 117.11M | N/A | |||
| Common Shares | 56.72M | 47.75M | 44.85M | 44.63M | 38.42M | |||
| Other Shareholders' Equity | 2.22M | 1.87M | -288.00K | -2.00K | 700.00K | |||
| Shares Outstanding | 56.72M | 47.75M | 44.85M | 44.63M | 46.62M | |||
| Tangible Book Value per Share | -0.03 | -0.22 | -0.29 | 0.36 | 0.06 | |||
| Total Shareholders' Equity | 15.89M | 7.38M | 9.96M | 16.36M | 3.38M | |||
| TOTAL LIABILITIES AND EQUITY | 69.23M | 56.39M | 58.36M | 39.13M | 19.85M | |||
| Statistics | ||||||||
| Debt/Equity | 0.25 | 3.08 | 2.22 | 0.82 | 3.65 | |||
| Current Ratio | 1.26 | 3.15 | 1.94 | 3.55 | 4.49 | |||
| Return On Assets (ROA) | -22.64% | -23.09% | -12.61% | -22.69% | -81.13% | |||
| Return On Equity (ROE) | -98.58% | -176.58% | -73.91% | -54.28% | -476.25% | |||
All data in EUR , ROIC based on taxRate of 0.21